Ono Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ono Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Taisho Pharmaceutical Holdings Co Ltd
sales of 280.09 billion Japanese Yen [US$2.53 billion]
of which 66%
Ohki Healthcare Holdings Co Ltd
(239.53 billion Japanese Yen [US$2.17 billion]
of which 43%
was Drug), and
Santen Pharmaceutical Company Limited
(224.94 billion Japanese Yen [US$2.03 billion]
of which 92%
was Medical pharmaceuticals).
Ono Pharmaceutical Co Ltd reported sales of ¥261.84 billion (US$2.37 billion)
March of 2018.
increase of 7.0%
versus 2017, when the company's sales were ¥244.80 billion.
This was the third consecutive year of growth at Ono Pharmaceutical Co Ltd.
Sales of Loyalty Other saw an increase
that was more than double the company's growth rate: sales were up
83.7% in 2018, from
¥30.46 billion to ¥55.95 billion.
Not all segments of Ono Pharmaceutical Co Ltd experienced an increase in sales in 2018:
sales of Products and Goods fell 3.9% to ¥205.89 billion.